Enhancing CAR T Cell Anti-Tumor Efficacy through Secreted Single Chain Variable Fragment (scFv) Immune Checkpoint Blockade

被引：0
|
作者：
Rafiq, Sarwish
Jackson, Hollie J.
Yeku, Oladapo
Purdon, Terence J.
van Leeuwen, Dayenne G.
Curran, Kevin J.
Ahmed, Ryan N.
Cullen, Grace D.
Yan, Su
Wang, Pei
Xiang, Jingyi
Liu, Cheng
Brentjens, Renier J.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
842
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Car T Cells Secreting an Immune Checkpoint Blockade scFv Have Enhanced Anti-Tumor Efficacy
    Rafiq, Sarwish
    Yeku, Oladapo
    Jackson, Hollie
    Purdon, Terence
    van Leeuwen, Dayenne
    Yan, Su
    Wang, Pei
    Xiang, Jingyi
    Liu, Cheng
    Brentjens, Renier
    MOLECULAR THERAPY, 2018, 26 (05) : 439 - 440
  • [2] CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
    Rafiq, Sarwish
    Yeku, Oladapo
    Jackson, Hollie
    Purdon, Terence
    van Leeuwen, Dayenne
    Yan, Su
    Wang, Pei
    Xiang, Jingyi
    Liu, Cheng
    Seshan, Venkatraman
    Brentjens, Renier
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
    Redmond, William L.
    Kasiewicz, Melissa J.
    Akporiaye, Emmanuel T.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [4] Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system
    Wang, Xiaohui
    Wu, Zhiqiang
    Qiu, Wei
    Chen, Ping
    Xu, Xiang
    Han, Weidong
    FRONTIERS OF MEDICINE, 2020, 14 (06) : 726 - 745
  • [5] Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system
    Xiaohui Wang
    Zhiqiang Wu
    Wei Qiu
    Ping Chen
    Xiang Xu
    Weidong Han
    Frontiers of Medicine, 2020, 14 : 726 - 745
  • [6] Dynamic Mechanisms of Immune Checkpoint Blockade for Controlling Anti-Tumor T Cells in Immune Microenvironments
    Ono, Masahiro
    Hassan, Jehanne
    Appleton, Elizabeth
    Pedersen, Malin
    Foo, Shane
    Reda, Omnia
    Satou, Yorifumi
    Okazaki, Il-Mi
    Okazaki, Taku
    Harrington, Kevin
    Melcher, Alan
    CANCER SCIENCE, 2025, 116 : 709 - 709
  • [7] ENHANCEMENT OF ANTI-TUMOR EFFICACY OF IMMUNE CHECKPOINT BLOCKADE BY ALPHATOCOPHERYLOXACETIC ACID-LYSINE
    Akporiaye, Emmanuel
    Redmond, William
    Kasiewicz, Melissa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A838 - A838
  • [8] Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor
    Zhao, Jingjing
    Dong, Jiebin
    Deng, Changwen
    Zhang, Qianjing
    Sun, Shicheng
    Li, Honggang
    Bai, Yun
    Deng, Hongkui
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [9] Talilmogene laherparepvec increases the anti-tumor efficacy of the anti PD-1 immune checkpoint blockade
    Piasecki, Julia
    Le, Tiep
    Ponce, Rafael
    Beers, Courtney
    CANCER RESEARCH, 2015, 75
  • [10] NKTR-214 enhances anti-tumor T cell immune responses induced by checkpoint blockade or vaccination
    Sharma, Meenu
    Fa'ak, Faisal
    Janssen, Louise
    Khong, Hiep
    Xiao, Zhilan
    Hailemichael, Yared
    Singh, Manisha
    Vianden, Christina
    Diab, Adi
    Zalevsky, Jonathan
    Hoch, Ute
    Overwijk, Willem
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345